Analyst Price Targets — OPCH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 27, 2026 2:44 pm | — | National Bank | $37.00 | $35.22 | StreetInsider | Option Care Health (OPCH) PT Raised to $37 at TD Cowen |
| January 16, 2026 12:33 pm | Michael Petusky | Barrington | $42.00 | $36.11 | TheFly | Option Care Health price target raised to $42 from $38 at Barrington |
| January 13, 2026 2:37 pm | Brian Tanquilut | Jefferies | $37.00 | $34.53 | StreetInsider | Option Care Health (OPCH) PT Raised to $37 at Jefferies |
| January 13, 2026 1:58 pm | David MacDonald | Truist Financial | $40.00 | $34.67 | StreetInsider | Truist Securities Reiterates Buy Rating on Option Care Health (OPCH) |
| December 10, 2025 9:14 pm | — | Stephens | $40.00 | $33.09 | TheFly | Option Care Health initiated with an Overweight at Stephens |
| October 31, 2025 9:56 am | Constantine Davides | JMP Securities | $36.00 | $26.21 | TheFly | Option Care Health price target lowered to $36 from $38 at Citizens JMP |
| October 17, 2025 8:59 am | — | Morgan Stanley | $35.00 | $27.10 | TheFly | Option Care Health initiated with an Overweight at Morgan Stanley |
| July 31, 2025 9:59 am | Constantine Davides | JMP Securities | $38.00 | $30.64 | TheFly | Option Care Health price target raised to $38 from $36 at Citizens JMP |
| January 23, 2025 10:12 am | Brian Tanquilut | Jefferies | $35.00 | $29.31 | TheFly | Option Care Health upgraded to Buy from Hold at Jefferies |
| November 4, 2024 1:48 pm | Jamie Perse | Goldman Sachs | $27.00 | $22.49 | StreetInsider | Goldman Sachs Downgrades Option Care Health (OPCH) to Neutral |
Latest News for OPCH
Option Care Health, Inc. (OPCH) Q4 2025 Earnings Call Transcript
Option Care (OPCH) came out with quarterly earnings of $0.46 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.35 per share a year ago.
BANNOCKBURN, Ill., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2025.
Option Care Health (NASDAQ: OPCH - Get Free Report) is anticipated to issue its Q4 2025 results before the market opens on Tuesday, February 24th. Analysts expect the company to announce earnings of $0.46 per share and revenue of $1.4633 billion for the quarter. Investors are encouraged to explore the company's upcoming Q4 2025 earning overview
Xcelerate (OTCMKTS:XCRT - Get Free Report) and Option Care Health (NASDAQ: OPCH - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership. Volatility and Risk Xcelerate has a beta of
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OPCH.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.